Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.300
+0.040 (1.23%)
Nov 5, 2024, 11:13 AM EST - Market open
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 76 employees as of December 31, 2023. The number of employees decreased by 13 or -14.61% compared to the previous year.
Employees
76
Change (1Y)
-13
Growth (1Y)
-14.61%
Revenue / Employee
$1,074,079
Profits / Employee
-$266,237
Market Cap
205.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nevro | 1,215 |
Biodesix | 217 |
Gossamer Bio | 135 |
Kodiak Sciences | 111 |
Nanobiotix | 102 |
Semler Scientific | 92 |
Orchestra BioMed Holdings | 56 |
Cybin | 50 |
FULC News
- 24 days ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - FMR LLC's Strategic Reduction in Fulcrum Therapeutics Inc Shares - GuruFocus
- 4 weeks ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Fulcrum Therapeutics Inc For Possible Securities Fraud - Accesswire
- 4 weeks ago - Fulcrum Therapeutics, Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Urges Shareholder Participation - Accesswire
- 5 weeks ago - Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Fulcrum Therapeutics Inc For Possible Securities Fraud - Accesswire
- 5 weeks ago - Fulcrum Therapeutics, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Invites Shareholders With Losses To Help - Accesswire
- 5 weeks ago - The Schall Law Firm Is Looking Into Whether Fulcrum Therapeutics Inc Committed Securities Fraud And Impacted Investors Should Reach Out - Accesswire
- 5 weeks ago - Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry Into Fulcrum Therapeutics, Inc. For Violating Securities Laws - Accesswire